
Cardiovascular, CNS, respiratory, gastrointestinal, renal IND filings are incomplete without the inclusion of safety pharmacology tests that assess the impact on the body’s major physiological systems like cardiovascular, respiratory and central nervous system behaviour.
Intox offers an integrated approach to GLP-regulatory safety pharmacology and non-GLP discovery pharmacology testing performed in compliance with the ICH S7A and S7B guidelines.